3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sleep Initiation and Maintenance Disorders
30
Neoplasms
21
Breast Neoplasms
19
Depression
12
Anxiety Disorders
12
Prostatic Neoplasms
8
Fatigue
8
Lung Neoplasms
5
Motor Activity
4
Lymphoma
4
Weight Loss
3
Uterine Cervical Neoplasms
3
Melanoma
3
Chronic Pain
3
Smoking Cessation
2
Sleep Wake Disorders
2
Pain
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Nervous System Diseases
2
Multiple Myeloma
2
Glioma
2
Glioblastoma
2
Colorectal Neoplasms
2
Cognitive Dysfunction
2
Carcinoma, Non-Small-Cell Lung
2
Weight Gain
1
Uterine Neoplasms
1
Tobacco Use Disorder
1
Interventions
Morphine
15
Oxycodone
13
Fentanyl
9
nabiximols
5
Methadone
5
Lidocaine
5
Acetaminophen
5
resiniferatoxin
4
Ethanol
4
Acupuncture Therapy
4
Transcutaneous Electric Nerve Stimulation
3
Hydromorphone
3
Transcranial Direct Current Stimulation
2
Surveys and Questionnaires
2
Standard of Care
2
Sodium Bicarbonate
2
Radiofrequency Ablation
2
Pharmaceutical Services
2
Naloxone
2
Ketamine
2
Electroacupuncture
2
Dronabinol
2
Control Groups
2
Buprenorphine
2
Analgesics, Opioid
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
rofecoxib
1
naloxegol
1
incobotulinumtoxinA
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cancer Pain
×
Cognitive Behavioral Therapy
×
Clear all
NCT05774197
2025-11-04
STAMP+CBT
University of Oklahoma
Phase NA
Completed
52 enrolled
7 charts